Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Short Interest Update

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) saw a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 3,730,000 shares, a growth of 11.3% from the March 15th total of 3,350,000 shares. Currently, 4.2% of the shares of the company are short sold. Based on an average daily volume of 565,100 shares, the days-to-cover ratio is presently 6.6 days.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on ACHC. Cantor Fitzgerald reissued a “neutral” rating and issued a $90.00 price target on shares of Acadia Healthcare in a report on Tuesday, March 5th. Stephens raised Acadia Healthcare from an “equal weight” rating to an “overweight” rating and set a $92.00 price target on the stock in a report on Friday, January 5th. TD Cowen boosted their target price on Acadia Healthcare from $86.00 to $101.00 and gave the stock an “outperform” rating in a research report on Friday, March 1st. Royal Bank of Canada restated an “outperform” rating and set a $94.00 price objective on shares of Acadia Healthcare in a report on Monday, March 4th. Finally, Mizuho boosted their price target on shares of Acadia Healthcare from $77.00 to $84.00 and gave the company a “neutral” rating in a report on Wednesday, March 6th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $91.22.

Acadia Healthcare Stock Performance

Shares of NASDAQ ACHC opened at $73.18 on Monday. The company has a market capitalization of $6.76 billion, a P/E ratio of -292.72, a price-to-earnings-growth ratio of 2.16 and a beta of 1.31. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.67 and a quick ratio of 0.67. Acadia Healthcare has a one year low of $66.49 and a one year high of $87.77. The business’s 50-day moving average price is $80.10 and its two-hundred day moving average price is $77.63.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Wednesday, February 28th. The company reported $0.85 EPS for the quarter, topping the consensus estimate of $0.80 by $0.05. The company had revenue of $742.80 million during the quarter, compared to the consensus estimate of $727.60 million. Acadia Healthcare had a negative net margin of 0.74% and a positive return on equity of 11.21%. The company’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.70 earnings per share. Analysts anticipate that Acadia Healthcare will post 3.57 earnings per share for the current fiscal year.

Insider Buying and Selling at Acadia Healthcare

In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of the business’s stock in a transaction on Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total transaction of $188,114.17. Following the completion of the transaction, the director now owns 46,074 shares in the company, valued at approximately $3,934,258.86. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 2.80% of the stock is owned by company insiders.

Institutional Investors Weigh In On Acadia Healthcare

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Mather Group LLC. acquired a new stake in shares of Acadia Healthcare in the first quarter valued at about $48,000. Vanguard Group Inc. grew its stake in shares of Acadia Healthcare by 0.3% in the fourth quarter. Vanguard Group Inc. now owns 8,861,427 shares of the company’s stock worth $689,065,000 after acquiring an additional 30,296 shares during the last quarter. Goldman Sachs Group Inc. raised its stake in Acadia Healthcare by 5.2% during the 4th quarter. Goldman Sachs Group Inc. now owns 454,793 shares of the company’s stock valued at $35,365,000 after purchasing an additional 22,290 shares during the last quarter. Price T Rowe Associates Inc. MD increased its holdings in shares of Acadia Healthcare by 3.6% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 130,509 shares of the company’s stock worth $10,149,000 after purchasing an additional 4,574 shares during the period. Finally, Public Employees Retirement System of Ohio lifted its stake in shares of Acadia Healthcare by 2.6% in the fourth quarter. Public Employees Retirement System of Ohio now owns 42,813 shares of the company’s stock valued at $3,329,000 after buying an additional 1,072 shares during the period.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.